奎斯特诊疗公布2026财年第一季度业绩 上调全年营收与每股收益指引

美股速递
Apr 21

医疗诊断服务巨头奎斯特诊疗(DGX)近日发布了2026财年第一季度财务报告,业绩表现亮眼。基于强劲的季度业绩和对未来市场的乐观预期,公司同时宣布上调2026全年的营收与每股收益(EPS)财务指引。

第一季度财务数据显示,奎斯特诊疗在营收和盈利能力方面均实现稳健增长。这一积极态势主要得益于诊断服务需求的持续回升以及公司在运营效率方面的持续优化。

鉴于当前业务的强劲势头和有利的市场环境,管理层决定提高对2026财年整体的业绩预期。新的指引反映了公司对核心业务增长潜力的信心,同时也考虑了其在创新诊断解决方案领域的战略布局所带来的积极影响。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10